306 related articles for article (PubMed ID: 26294790)
1. Association of growth differentiation factor 11/8, putative anti-ageing factor, with cardiovascular outcomes and overall mortality in humans: analysis of the Heart and Soul and HUNT3 cohorts.
Olson KA; Beatty AL; Heidecker B; Regan MC; Brody EN; Foreman T; Kato S; Mehler RE; Singer BS; Hveem K; Dalen H; Sterling DG; Lawn RM; Schiller NB; Williams SA; Whooley MA; Ganz P
Eur Heart J; 2015 Dec; 36(48):3426-34. PubMed ID: 26294790
[TBL] [Abstract][Full Text] [Related]
2. Growth differentiation factor 15 and cardiovascular events in patients with stable ischemic heart disease (The Heart and Soul Study).
Schopfer DW; Ku IA; Regan M; Whooley MA
Am Heart J; 2014 Feb; 167(2):186-192.e1. PubMed ID: 24439979
[TBL] [Abstract][Full Text] [Related]
3. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study.
Ix JH; Shlipak MG; Chertow GM; Whooley MA
Circulation; 2007 Jan; 115(2):173-9. PubMed ID: 17190862
[TBL] [Abstract][Full Text] [Related]
4. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
[TBL] [Abstract][Full Text] [Related]
5. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
Okin PM
J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin is associated with increased mortality and heart failure in patients with stable ischemic heart disease: data from the Heart and Soul Study.
Beatty AL; Zhang MH; Ku IA; Na B; Schiller NB; Whooley MA
Atherosclerosis; 2012 Feb; 220(2):587-92. PubMed ID: 22196150
[TBL] [Abstract][Full Text] [Related]
7. NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease.
Kohli P; Steg PG; Cannon CP; Smith SC; Eagle KA; Ohman EM; Alberts MJ; Hoffman E; Guo J; Simon T; Sorbets E; Goto S; Bhatt DL;
Am J Med; 2014 Jan; 127(1):53-60.e1. PubMed ID: 24280110
[TBL] [Abstract][Full Text] [Related]
8. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.
deFilippi C; Wasserman S; Rosanio S; Tiblier E; Sperger H; Tocchi M; Christenson R; Uretsky B; Smiley M; Gold J; Muniz H; Badalamenti J; Herzog C; Henrich W
JAMA; 2003 Jul; 290(3):353-9. PubMed ID: 12865376
[TBL] [Abstract][Full Text] [Related]
9. Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE study.
Boman K; Gerdts E; Wachtell K; Dahlöf B; Nieminen MS; Olofsson M; Papademetriou V; Devereux RB
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):242-8. PubMed ID: 19369828
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of 'in-treatment' wall motion abnormalities in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Cicala S; de Simone G; Wachtell K; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
J Hypertens; 2008 Apr; 26(4):806-12. PubMed ID: 18327092
[TBL] [Abstract][Full Text] [Related]
11. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B;
JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of increased left ventricular mass index to mortality and sudden death in patients with stable coronary heart disease (from the Heart and Soul Study).
Turakhia MP; Schiller NB; Whooley MA
Am J Cardiol; 2008 Nov; 102(9):1131-5. PubMed ID: 18940278
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of growth differentiation factor 11 (GDF11) levels in dogs with chronic mitral valve insufficiency.
Ahn ST; Suh SI; Moon H; Hyun C
Can J Vet Res; 2016 Jan; 80(1):90-2. PubMed ID: 26733738
[TBL] [Abstract][Full Text] [Related]
14. Mitral annular calcium, inducible myocardial ischemia, and cardiovascular events in outpatients with coronary heart disease (from the Heart and Soul Study).
Holtz JE; Upadhyaya DS; Cohen BE; Na B; Schiller NB; Whooley MA
Am J Cardiol; 2012 Apr; 109(8):1092-6. PubMed ID: 22245404
[TBL] [Abstract][Full Text] [Related]
15. Association of resistin with heart failure and mortality in patients with stable coronary heart disease: data from the heart and soul study.
Zhang MH; Na B; Schiller NB; Whooley MA
J Card Fail; 2011 Jan; 17(1):24-30. PubMed ID: 21187261
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study.
Verma A; Meris A; Skali H; Ghali JK; Arnold JM; Bourgoun M; Velazquez EJ; McMurray JJ; Kober L; Pfeffer MA; Califf RM; Solomon SD
JACC Cardiovasc Imaging; 2008 Sep; 1(5):582-91. PubMed ID: 19356485
[TBL] [Abstract][Full Text] [Related]
17. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
Bang CN; Devereux RB; Okin PM
J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
[TBL] [Abstract][Full Text] [Related]
18. Association of myocardial deformation with mortality independent of myocardial ischemia and left ventricular hypertrophy.
Stanton T; Ingul CB; Hare JL; Leano R; Marwick TH
JACC Cardiovasc Imaging; 2009 Jul; 2(7):793-801. PubMed ID: 19608127
[TBL] [Abstract][Full Text] [Related]
19. Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative.
von Lueder TG; Girerd N; Atar D; Agewall S; Lamiral Z; Kanbay M; Pitt B; Dickstein K; Zannad F; Rossignol P;
Eur J Heart Fail; 2015 Nov; 17(11):1144-51. PubMed ID: 26424212
[TBL] [Abstract][Full Text] [Related]
20. Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study.
Ix JH; Shlipak MG; Chertow GM; Ali S; Schiller NB; Whooley MA
J Card Fail; 2006 Oct; 12(8):601-7. PubMed ID: 17045178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
